Ya-jing Chen
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Oculomotor impairments in de novo Parkinson's disease.
Journal: Frontiers in aging neuroscience
Published: July 04, 2022
Fisetin Regulates Gut Microbiota and Exerts Neuroprotective Effect on Mouse Model of Parkinson's Disease.
Journal: Frontiers in neuroscience
Published: April 28, 2020
TET2-mediated Cdkn2A DNA hydroxymethylation in midbrain dopaminergic neuron injury of Parkinson's disease.
Journal: Human molecular genetics
Published: October 22, 2019
Corrigendum to: TET2-mediated Cdkn2A DNA hydroxymethylation in midbrain dopaminergic neuron injury of Parkinson's disease.
Journal: Human molecular genetics
Published: June 23, 2019
Therapeutic Potential of a Prolyl Hydroxylase Inhibitor FG-4592 for Parkinson's Diseases in Vitro and in Vivo: Regulation of Redox Biology and Mitochondrial Function.
Journal: Frontiers in aging neuroscience
Published: February 19, 2018
Enantioselective Rhodium-Catalyzed Alkenylation of Aliphatic Imines.
Journal: Organic letters
Published: October 10, 2017
Synthesis of chiral cyclobutanes via rhodium/diene-catalyzed asymmetric 1,4-addition: a dramatic ligand effect on the diastereoselectivity.
Journal: Chemical communications (Cambridge, England)
Published: April 28, 2015
Enantioselective rhodium-catalyzed arylation of cyclic N-sulfamidate alkylketimines: a new access to chiral β-alkyl-β-aryl amino alcohols.
Journal: Organic letters
Published: June 13, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026